News‎ > ‎Full Stories‎ > ‎

3 April 2017

posted Apr 3, 2017, 3:12 AM by Beck Lockwood   [ updated Apr 3, 2017, 3:24 AM ]
Large-scale lung cancer screening trial launched

A large-scale lung cancer screening trial has been launched in Yorkshire in a bid to find out how screening could be implemented to significantly cut deaths from the disease.

Lung cancer is one of the region’s biggest killers, with around 4,500 people diagnosed each year – most of these patients will have advanced, incurable cancer. There is currently no system in the UK for screening people to detect the disease at an earlier stage.

The trial, funded byYorkshire Cancer Research, will start in 2018 and will see mobile screening vans visiting communities in the Leeds area. The research will help determine who should be invited for screening, with the results being used to plan a national programme.

The trial is led by Dr Matthew Callister, Consultant in Respiratory Medicine at Leeds Teaching Hospitals NHS Trust with co-investigators from the NIHR DEC Leeds including Prof Richard Neal and Dr Michael Messenger. The role of the DEC is to add value to the study by identifying partner companies who can carry out diagnostic testing to identify high risk patients who might benefit from screening. Through the support of the NIHR DEC Leeds the programme also aims to create a 7,000 patient biobank to accelerate research into diagnosis and treatment of lung cancer.

Dr Matthew Callister explains: “Checking people at high risk of lung cancer with regular scans detects early, curable cancer and reduces deaths by one fifth.

“Lung cancer screening is not currently available in the UK, and it is not clear exactly which people would most benefit.”